Pacira Ireland

Company snapshot

Pacira Ireland maintains 100 tracked programs across Postoperative Pain, Pain, Postoperative Pain Management, Osteoarthritis, Knee, Pain, Postoperative, Bunion, Osteoarthritis of the Knee, Bowel Obstruction, Total Knee Arthroplasty, Knee Osteoarthritis, Facial Wrinkles, Rotator Cuff Tear. Momentum score: 20/100 (30-day delta: n/a). Public registry data covers pipeline phase, clinical trials, paten

• 3 approved product(s) across US/EU regulatory metadata.
• 100 active pipeline program(s) linked via ClinicalTrials.gov.
• 57 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Pacira Ireland. Not investment advice.

• Peer + 0 momentum

  Vera Therapeutics

  TA overlap score 25

Recent activity

Latest pipeline, patent, and corporate events for Pacira Ireland.

1. Jun 8, 2026 Clinical update

   Triamcinolone Acetonide Extended-Release Injectable Suspension — Phase 1

2. Jun 8, 2026 Clinical update

   SKY0402 + bupivacaine HCl — Phase 2

3. Jun 8, 2026 Clinical update

   morphine sulfate — Approved

4. Jun 8, 2026 Clinical update

   Methadone — Approved

5. Jun 8, 2026 Clinical update

   Low Dose SKY0402 — Phase 2

View all clinical trial activity →

• What is Pacira Ireland?

  Pacira Ireland is a pharma organization headquartered in Ranelagh, IE. It trades on NYSE under ticker PCRX. Primary therapeutic focus areas include Postoperative Pain, Pain, Postoperative Pain Management, Osteoarthritis, Knee, Pain, Postoperative. NovaPharmaNews links 100 clinica

• Is Pacira Ireland publicly traded?

  Yes. Pacira Ireland is listed with ticker PCRX on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Pacira Ireland develop or market?

  We link 32 drug profile(s) where Pacira Ireland is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/pacira-biosciences#company-drugs.

• What are the latest developments for Pacira Ireland?

  In the last 12 months our linked public records show 100 trial program update(s) and 3 US patent grant(s) tied to this profile.

• What therapeutic areas does Pacira Ireland focus on?

  Pacira Ireland focuses on Postoperative Pain, Pain, Postoperative Pain Management based on our analysis of their pipeline programs and drug development activities.